Examinando por Autor "Vásquez Bustamante, Roxana Marianela"
Mostrando 1 - 2 de 2
- Resultados por página
- Opciones de ordenación
Ítem Acceso abierto Effectiveness of Captopril treatment in patients with hypertensive crises(Universidad Privada Norbert Wiener, 2017-11-12) Sánchez Quispe, Diego; Vásquez Bustamante, Roxana Marianela; Calsin Pacompia, WilmerObjective: To systematize and analyze the evidence on the effectiveness of captopril treatment in hypertensive crises. Materials and Methods: This is an observational and retrospective systematic review, with a search restricted to full-text articles, and selected articles underwent critical reading. Of the 11 articles, 28% (03) are from Cuba, 18% (02) from Mexico, 18% (02) from Brazil, 9% (01) from the USA, 9% (01) from Iran, 9% (01) from Turkey, and 9% (01) from Bosnia. Systematic review with 9% from Brazil, quasi-experimental studies with 9% from Mexico and Bosnia, and clinical trials with 9% from Cuba, Iran, and Mexico, respectively. 18% of the studies are cross-sectional descriptive studies from Cuba, 9% from Brazil, 9% from Turkey, and 9% from the USA. 100% of the analyzed articles affirm that captopril is effective in the treatment of hypertensive crises. Results: E. Karakilic et al. demonstrate that captopril is an effective, easy-to-administer, and safe treatment for hypertensive crises, starting its action from 15 to 120 minutes after administration, reducing the mean blood pressure by 25%, as recommended by European and North American guidelines. This is consistent with Maleki A et al., who evaluated nifedipine, captopril, or sublingual nitroglycerin, which can reduce blood pressure the most? Conclusion: The reviewed studies provide evidence of the efficacy of captopril in treating hypertensive crises.Ítem Acceso abierto Effectiveness of Captopril treatment in patients with hypertensive crises(Universidad Privada Norbert Wiener, 2017-11-12) Sánchez Quispe, Diego; Vásquez Bustamante, Roxana Marianela; Calsin Pacompia, WilmerObjective: To systematize and analyze the evidence on the effectiveness of captopril treatment in hypertensive crises. Materials and Methods: This is an observational and retrospective systematic review, with a search restricted to full-text articles, and selected articles underwent critical reading. Of the 11 articles, 28% (03) are from Cuba, 18% (02) from Mexico, 18% (02) from Brazil, 9% (01) from the USA, 9% (01) from Iran, 9% (01) from Turkey, and 9% (01) from Bosnia. Systematic review with 9% from Brazil, quasi-experimental studies with 9% from Mexico and Bosnia, and clinical trials with 9% from Cuba, Iran, and Mexico, respectively. 18% of the studies are cross-sectional descriptive studies from Cuba, 9% from Brazil, 9% from Turkey, and 9% from the USA. 100% of the analyzed articles affirm that captopril is effective in the treatment of hypertensive crises. Results: E. Karakilic et al. demonstrate that captopril is an effective, easy-to-administer, and safe treatment for hypertensive crises, starting its action from 15 to 120 minutes after administration, reducing the mean blood pressure by 25%, as recommended by European and North American guidelines. This is consistent with Maleki A et al., who evaluated nifedipine, captopril, or sublingual nitroglycerin, which can reduce blood pressure the most? Conclusion: The reviewed studies provide evidence of the efficacy of captopril in treating hypertensive crises.
